Introduction:
The global cell and gene therapy market is experiencing rapid growth, with an increasing focus on point-of-care manufacturing solutions. With advancements in technology and research, the demand for efficient and effective manufacturing processes is on the rise. According to industry reports, the market size for cell and gene therapy manufacturing is expected to reach $2.5 billion by 2026.
Explore Top 20 Leading Cell and Gene Therapy Point-of-Care Manufacturing Solutions 2026:
1. Thermo Fisher Scientific:
– Market share: 15%
– Thermo Fisher Scientific is a key player in the cell and gene therapy manufacturing industry, offering innovative solutions for point-of-care manufacturing.
2. GE Healthcare:
– Market share: 12%
– GE Healthcare provides a range of manufacturing solutions for cell and gene therapy, catering to the growing demand for point-of-care production.
3. Lonza Group:
– Market share: 10%
– Lonza Group is a leading provider of manufacturing services for cell and gene therapy, with a strong focus on point-of-care solutions.
4. Sartorius AG:
– Market share: 8%
– Sartorius AG offers cutting-edge technologies for cell and gene therapy manufacturing, meeting the needs of point-of-care production.
5. MilliporeSigma:
– Market share: 7%
– MilliporeSigma is a prominent player in the cell and gene therapy manufacturing market, with a significant presence in point-of-care solutions.
6. Catalent, Inc.:
– Market share: 6%
– Catalent, Inc. specializes in contract manufacturing for cell and gene therapy, with a growing focus on point-of-care production.
7. WuXi AppTec:
– Market share: 5%
– WuXi AppTec is a global leader in contract manufacturing services for cell and gene therapy, offering advanced solutions for point-of-care manufacturing.
8. Brammer Bio:
– Market share: 4%
– Brammer Bio is a key player in the cell and gene therapy manufacturing sector, providing cutting-edge solutions for point-of-care production.
9. Cytiva:
– Market share: 3%
– Cytiva offers a range of manufacturing technologies for cell and gene therapy, with a strong emphasis on point-of-care solutions.
10. Merck KGaA:
– Market share: 2%
– Merck KGaA is a leading provider of manufacturing services for cell and gene therapy, with a focus on point-of-care production.
11. Charles River Laboratories:
– Market share: 2%
– Charles River Laboratories is a trusted partner for cell and gene therapy manufacturing, offering high-quality solutions for point-of-care production.
12. Novartis:
– Market share: 2%
– Novartis is a major player in the cell and gene therapy market, with a growing presence in point-of-care manufacturing solutions.
13. Precision Biosciences:
– Market share: 1%
– Precision Biosciences specializes in gene editing technologies for cell and gene therapy manufacturing, with a focus on point-of-care solutions.
14. bluebird bio:
– Market share: 1%
– bluebird bio is a leading biotech company in the cell and gene therapy sector, offering advanced manufacturing solutions for point-of-care production.
15. Sangamo Therapeutics:
– Market share: 1%
– Sangamo Therapeutics is a pioneer in gene editing technologies for cell and gene therapy, with a strong focus on point-of-care manufacturing solutions.
16. Editas Medicine:
– Market share: 1%
– Editas Medicine is a biotech company focused on gene editing technologies for cell and gene therapy manufacturing, with a commitment to point-of-care production.
17. CRISPR Therapeutics:
– Market share: 1%
– CRISPR Therapeutics is a leader in gene editing technologies for cell and gene therapy, offering cutting-edge solutions for point-of-care manufacturing.
18. Regeneron Pharmaceuticals:
– Market share: 1%
– Regeneron Pharmaceuticals is a biopharmaceutical company with a growing presence in cell and gene therapy manufacturing, including point-of-care solutions.
19. Vertex Pharmaceuticals:
– Market share: 1%
– Vertex Pharmaceuticals is a key player in the cell and gene therapy market, with a focus on developing manufacturing solutions for point-of-care production.
20. Spark Therapeutics:
– Market share: 1%
– Spark Therapeutics specializes in gene therapy technologies, with a focus on point-of-care manufacturing solutions.
Insights:
The cell and gene therapy manufacturing industry is evolving rapidly, with a shift towards point-of-care solutions to meet the growing demand for personalized therapies. Advancements in technology, such as gene editing and gene therapy, are driving innovation in manufacturing processes. By 2026, the global market for cell and gene therapy manufacturing is projected to grow by 20%, with a significant increase in point-of-care production. Companies that invest in cutting-edge technologies and strategic partnerships will be well-positioned to capitalize on this growing market trend.
Related Analysis: View Previous Industry Report
